Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pain Medicine

Is Quantitative Sensory Testing Needed for Nociplastic Pain?

At a Glance

Quantitative sensory testing measures how you respond to pressure, temperature, and repeated touch, but it is not required to diagnose nociplastic pain. A clinician usually relies on your pain history, symptoms, and physical examination, using QST only as optional supporting information.

Quantitative sensory testing (QST) is a specialized evaluation that measures how your nervous system processes physical sensations like pressure and temperature [1]. While QST can provide valuable information about how your body experiences pain, you do not need it to be diagnosed with nociplastic pain [2]. A clinician can typically make an assessment and discuss treatment based on your medical history, a physical examination, and an evaluation of your symptoms without needing this test [3][4]. QST is an optional tool that may help identify or characterize altered sensory responses, but it is not a routine diagnostic requirement [1].

What Does Quantitative Sensory Testing Measure?

During a QST session, a clinician uses calibrated instruments to apply specific, controlled sensations to your skin and asks you to report when you first detect them and when they begin to feel painful [1][5]. This helps map out your sensory profile, identifying areas where you might have sensory loss or sensory gain [1][6]. Sensory gain can include:

  • Allodynia: Feeling pain in response to a trigger that normally shouldn’t hurt, such as a light touch or the brush of clothing [6].
  • Hyperalgesia: Feeling a severely painful response to a mildly painful trigger [6].

A typical QST assessment may include several different types of tests:

  • Pressure testing: The clinician uses a device called an algometer to press against your skin or muscles to determine exactly how much pressure it takes for the sensation to change from mere pressure to pain (your pressure pain threshold) [7][8].
  • Heat and cold testing: Using small temperature probes, the tester determines the exact point at which you first detect warmth or cold, and at what temperature it begins to feel painful [7][9].
  • Repeated stimuli: The clinician may gently tap or prick an area repeatedly. For some people, the sensation becomes increasingly painful with each tap, even though the pressure hasn’t changed [10]. This measures temporal summation, a psychophysical response related to a neurophysiological concept called “wind-up” [11]. While it shows how the nervous system amplifies pain signals over time, not everyone with nociplastic pain experiences it, and it can also occur in other conditions [10][11].

What to Expect During the Test

  • Procedures vary in length but comprehensive testing can take an hour or more [12].
  • The stimuli may be uncomfortable, but they are not intended to cause injury [1]. You can always ask to pause or stop the test.
  • Ask your clinic beforehand if you should continue taking your regular pain medications or make any other preparations.

Why QST is Not Required for Diagnosis

Nociplastic pain occurs when the nervous system’s pain processing is altered, despite no clear evidence that the pain is fully explained by ongoing tissue injury (nociceptive pain) or a disease or lesion of the somatosensory nervous system (neuropathic pain) [4]. These different pain mechanisms are not mutually exclusive and can often coexist [13].

Because diagnosing nociplastic pain involves identifying a clinical pattern, it does not rely on a single laboratory test [4]. Clinicians typically look for pain lasting more than three months that has a regional, multifocal, or widespread distribution, along with clinical signs of hypersensitivity that cannot be entirely explained by another cause [4][14].

While QST can add context to your sensory profile, there is no single definitive QST result that proves or excludes nociplastic pain [2]. Sensitization can happen alongside other conditions [4][13]. Furthermore, a normal QST result does not mean your pain is not real. Therefore, QST results are always interpreted alongside your history and physical exam [3][15].

Limitations of Quantitative Sensory Testing

If your clinician does not order QST, it may be because of its practical limitations:

  • Availability: Comprehensive QST requires costly equipment and specially trained personnel, meaning availability varies and it is typically found at major research centers or specialized pain clinics [12].
  • Protocol differences: Different clinics might test different body parts, use different equipment, or phrase their instructions differently, all of which can change the results [16][17].
  • Influence of other factors: QST largely depends on your conscious responses. Your results can be influenced by your attention, comprehension, fatigue, mood, sleep quality, and the testing environment [12][18]. Trained clinicians interpret the results with these factors in mind, rather than treating the numbers as absolute proof.
What QST Can Do What QST Cannot Do
Measure your sensory detection and pain thresholds [1] Prove or disprove that your pain is real [2]
Help describe your sensory profile (sensory gain or loss) [1] Show tissue damage or visible nerve lesions [4]
Add context to a clinical assessment [1] Provide a stand-alone diagnosis of nociplastic pain [2]

(Note: New or progressive weakness, numbness, balance problems, bowel or bladder changes, or fever are not typical features of nociplastic pain and always warrant prompt medical evaluation.)

Common questions in this guide

Do I need quantitative sensory testing to be diagnosed with nociplastic pain?
Usually not. Clinicians can often assess nociplastic pain using your pain history, physical examination, symptom duration and distribution, and signs of increased sensitivity. QST is an optional test that may add context but is not a routine requirement.
What happens during a quantitative sensory testing appointment?
A clinician applies controlled pressure, heat, cold, or repeated touch or pricking and asks when you first notice the sensation and when it becomes painful. The test may be uncomfortable but should not cause injury, and you can ask to pause or stop.
Can QST prove that I have nociplastic pain?
No. QST measures sensory thresholds and can describe increased or reduced sensitivity, but no single result proves or rules out nociplastic pain. Clinicians interpret the findings together with your medical history and physical examination.
What does a normal QST result mean for my pain?
A normal result does not mean your pain is not real and does not by itself exclude nociplastic pain. Attention, understanding, fatigue, mood, sleep, and the testing environment can affect results, so clinicians consider the full clinical picture.
Why might my clinician decide not to order QST?
Your history and physical examination may already provide enough information for assessment and treatment planning. QST may also be unavailable because it requires specialized equipment and training, and differences between testing protocols can make results harder to compare.
Which symptoms should be evaluated promptly rather than assumed to be nociplastic pain?
New or progressive weakness, numbness, balance problems, bowel or bladder changes, or fever are not typical features of nociplastic pain. Contact a healthcare professional promptly if you develop these symptoms.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Nociplastic Pain.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do my clinical symptoms and physical exam provide enough information for an assessment, or would specialized sensory testing be helpful?
  2. 2.What would you do differently in my treatment plan if a sensory test were normal versus abnormal?
  3. 3.Are you recommending testing to rule out other specific conditions, or simply to characterize my pain?
  4. 4.How do the specific areas of hypersensitivity I am experiencing fit into my overall diagnosis?

References

References (18)
  1. 1

    Quantitative sensory testing (QST). English version.

    Mücke M, Cuhls H, Radbruch L, et al.

    Schmerz (Berlin, Germany) 2021; (35(Suppl 3)):153-160 doi:10.1007/s00482-015-0093-2.

    PMID: 26826097
  2. 2

    Application of the grading system for "nociplastic pain" in chronic primary and chronic secondary pain conditions: a field study.

    Schmidt H, Drusko A, Renz MP, et al.

    Pain 2025; (166(1)):196-211 doi:10.1097/j.pain.0000000000003355.

    PMID: 39190340
  3. 3

    Application of a Clinical Approach to Diagnosing Primary Pain: Prevalence and Correlates of Primary Back and Neck Pain in a Community Physiatry Clinic.

    Schubiner H, Lowry WJ, Heule M, et al.

    The journal of pain 2024; (25(3)):672-681 doi:10.1016/j.jpain.2023.09.019.

    PMID: 37777033
  4. 4

    The concept of nociplastic pain-where to from here?

    Kosek E

    Pain 2024; (165(11S)):S50-S57 doi:10.1097/j.pain.0000000000003305.

    PMID: 39560415
  5. 5

    Quantitative sensory testing: identifying pain characteristics in patients with osteoarthritis.

    Arant KR, Katz JN, Neogi T

    Osteoarthritis and cartilage 2022; (30(1)):17-31 doi:10.1016/j.joca.2021.09.011.

    PMID: 34597800
  6. 6

    Somatosensory assessment and conditioned pain modulation in temporomandibular disorders pain patients.

    Kothari SF, Baad-Hansen L, Oono Y, Svensson P

    Pain 2015; (156(12)):2545-2555 doi:10.1097/j.pain.0000000000000325.

    PMID: 26307861
  7. 7

    Preoperative pain mechanisms assessed by cuff algometry are associated with chronic postoperative pain relief after total knee replacement.

    Petersen KK, Graven-Nielsen T, Simonsen O, et al.

    Pain 2016; (157(7)):1400-1406 doi:10.1097/j.pain.0000000000000531.

    PMID: 27331347
  8. 8

    Reliability of Quantitative Sensory Tests in a Low Back Pain Population.

    Vuilleumier PH, Biurrun Manresa JA, Ghamri Y, et al.

    Regional anesthesia and pain medicine 2015; (40(6)):665-73 doi:10.1097/AAP.0000000000000289.

    PMID: 26222349
  9. 9

    Thermal pain tolerance and pain rating in normal subjects: Gender and age effects.

    Lue YJ, Wang HH, Cheng KI, et al.

    European journal of pain (London, England) 2018; (22(6)):1035-1042 doi:10.1002/ejp.1188.

    PMID: 29388295
  10. 10

    The interrater and test-retest reliability of 3 modalities of quantitative sensory testing in healthy adults and people with chronic low back pain or rheumatoid arthritis.

    Brady SM, Georgopoulos V, Veldhuijzen van Zanten JJCS, et al.

    Pain reports 2023; (8(6)):e1102 doi:10.1097/PR9.0000000000001102.

    PMID: 37829138
  11. 11

    A clinically feasible method for the assessment and characterization of pain in patients with chronic pancreatitis.

    Phillips AE, Faghih M, Kuhlmann L, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2020; (20(1)):25-34 doi:10.1016/j.pan.2019.11.007.

    PMID: 31787527
  12. 12

    Quantitative Sensory Testing - From bench to bedside.

    Hughes S, Vollert J, Freeman R, Forstenpointner J

    International review of neurobiology 2024; (179()):67-90 doi:10.1016/bs.irn.2024.10.011.

    PMID: 39580222
  13. 13

    Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a systematic review.

    Shraim MA, Massé-Alarie H, Hodges PW

    Pain 2021; (162(4)):1007-1037 doi:10.1097/j.pain.0000000000002113.

    PMID: 33136983
  14. 14

    Current understanding of nociplastic pain.

    Yoo YM, Kim KH

    The Korean journal of pain 2024; (37(2)):107-118 doi:10.3344/kjp.23326.

    PMID: 38504389
  15. 15

    CENTRAL SENSITIZATION IN PATIENTS WITH CHRONIC MUSCULOSKELETAL PAIN.

    Tomašević-Todorović S, Spasojević T

    Acta clinica Croatica 2023; (62(Suppl4)):102-106 doi:10.20471/acc.2023.62.s4.15.

    PMID: 40463460
  16. 16

    Quantitative Sensory Testing in Fibromyalgia Syndrome: A Scoping Review.

    Carneiro AM, de Góes Salvetti M, Dale CS, da Silva VA

    Biomedicines 2025; (13(4)) doi:10.3390/biomedicines13040988.

    PMID: 40299678
  17. 17

    Verbal instructions influence pain thresholds assessment: A study using manual and electronic mechanical stimulators.

    Suzuki K, Baad-Hansen L, Svensson P

    European journal of pain (London, England) 2017; (21(5)):900-906 doi:10.1002/ejp.992.

    PMID: 28106324
  18. 18

    Quantitative sensory testing in pain management.

    Roldan CJ, Abdi S

    Pain management 2015; (5(6)):483-91 doi:10.2217/pmt.15.37.

    PMID: 26399563

This page explains quantitative sensory testing and nociplastic pain for educational purposes; it cannot diagnose your pain or replace advice from your clinician. Ask your healthcare professional how your symptoms and examination should guide testing and care.